The injection of a melanocortin peptide or of melanocortin peptide analogue
s into the cerebrospinal fluid or into the ventromedial hypothalamus in nan
omolar or subnanomolar doses induces a long-lasting inhibition of food inta
ke. The effect keeps significant for up to 9 h and has been observed in all
animal species so far tested, the most susceptible being the rabbit. The a
norectic effect of these peptides is a primary one, not secondary to the sh
ift towards other components of the complex melanocortin-induced behavioral
syndrome, in particular grooming. The site of action is in the brain, and
the effect is not adrenal-mediated because it is fully exhibited also by ad
renalectomized animals. It is a very strong effect, because the degree of f
eeding inhibition is not reduced in conditions of hunger, either induced by
24 h starvation, or by insulin-induced hypoglycemia, or by stimulation of
gamma-aminobutyric acid (GABA), noradrenergic or opioid systems. The micros
tructural analysis of feeding behavior suggests that melanocortins act as s
atiety-inducing agents, because they do not significantly modify the latenc
ies to start eating, but shorten the latencies to stop eating. The mechanis
m of action involves the activation of melanocortin MC4 receptors, because
selective melanocortin MC4 receptor antagonists inhibit the anorectic effec
t of melanocortins, while inducing per se a strong stimulation of food inta
ke and a significant increase in body weight. Melanocortins seem to play an
important role in stress-induced anorexia, because such condition, in rats
, is significantly attenuated by the blockage of melanocortin MC4 receptors
; such a role is not secondary to an increased release of corticotropin-rel
easing factor (CRF), because, on the other hand, the CRF-induced anorexia i
s not affected at all by the blockage of melanocortin MC4 receptors. The ph
ysiological meaning of the feeding inhibitory effect of melanocortins, and,
by consequence, the physiological role of melanocortins in the complex mac
hinery responsible for body weight homeostasis, is testified by the hyperph
agia/obesity syndromes caused by mutations in the pro-opiomelano-cortin (PO
MC) gene, or in the melanocortin MC4 receptor gene, or in the agouti locus.
Finally, recent evidences suggest that melanocortins could be involved in
mediating the effects of leptin, and in controlling the expression of neuro
peptide Y (NPY). (C) 2000 Elsevier Science B.V. All rights reserved.